In a transformative move for Oklahoma City’s burgeoning biotech landscape, a substantial $600,000 allocation from the Oklahoma City Economic Development Authority is set to catalyze the creation of a $46.7 million medical research lab by ARL Bio Pharma. This ambitious project not only promises to
In an era where healthcare precision is paramount, the global market for in vitro diagnostics (IVD) quality control is experiencing remarkable growth, driven by an urgent need for accurate and reliable diagnostic testing. With chronic and infectious diseases on the rise, alongside rapid
In a landscape where public health crises and legal battles shape regulatory frameworks, the U.S. Food and Drug Administration (FDA) has recently made significant strides in refining its approach to in vitro diagnostic (IVD) tests. These updates come at a critical juncture, as the demand for rapid
In a remarkable leap forward for brain health diagnostics, C2N Diagnostics, a trailblazing company based in St. Louis, Missouri, has taken a historic step by submitting an innovative blood test for Alzheimer’s disease to the U.S. Food and Drug Administration (FDA) for review. This development could
Malaria remains a formidable global health crisis, taking an immense toll on lives, especially in Africa where it accounts for approximately 95% of all fatalities from the disease, presenting a particularly insidious challenge in curbing this epidemic through the silent spread of asymptomatic
In the high-stakes world of healthcare, laboratory errors pose a silent threat to patient safety, often leading to misdiagnoses, delayed treatments, and eroded trust in medical systems, making their prevention a critical priority for hospitals. These mistakes, whether from a mislabeled specimen or
